Freiman Paul E. 4
4 · NovaBay Pharmaceuticals, Inc. · Filed May 24, 2022
Insider Transaction Report
Form 4
Freiman Paul E.
Director
Transactions
- Exercise/Conversion
Common Stock
2022-05-21+30,000→ 30,000 total - Exercise/Conversion
Restricted Stock Units
2022-05-21−30,000→ 30,000 total→ Common Stock (30,000 underlying)
Holdings
- 2,311(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant.